Recent Increase in Contraception Use Noted Among US Teenagers
Increases in use of 1 or more contraceptive methods, dual-method use, long-acting reversibles.
Contraception
Hormonal Contraceptives and Migraine: Is It Time to Revisit Stroke Risk?
Current oral contraceptive products contain lower doses of estrogen than those used in the past, prompting reconsideration of risks and benefits.
Assessing a Comprehensive Long-Acting Reversible Contraceptive Program
An evaluation assessed the nonhealthcare-related influences that have led to misconceptions about long-acting reversible contraceptives.
Oral Contraceptive Taytulla Recalled Due to Packaging Error
A physician report indicates that 4 placebo (non-hormonal) capsules were placed in the first 4 days of therapy instead of active capsules.
Number of IUD Insertions Increases After ACA Contraceptive Mandate
Increase in use depends on the amount of reduction in out-of-pocket costs
Bacterial vaginosis may alter links between contraception, HIV acquisition
Bacterial vaginosis may cause an increased risk for HIV acquisition in women taking oral or injectable hormonal contraception.
Ovarian cancer risk reduced with oral contraceptives
The use of oral contraceptives did not reduce the risks of breast cancer or colorectal cancer.
Long-acting reversible contraceptives: a review
Because of the high number of unintended pregnancies and the effectiveness of LARCs, they should be a first-line contraceptive option for most women.
Hormonal contraception use linked to an increased risk of breast cancer
Breast cancer diagnosis is higher among women who currently use or recently used contemporary hormonal contraceptives than among women who have never used hormonal contraceptives.
CDC updates contraception recommendations for women at risk for HIV
The CDC revised its US Medical Eligibility Criteria for Contraceptive Use categorization for DMPA injection in women at high risk for HIV infection from US MEC category 1 to US MEC category 2.
Next post in HIV/AIDS Information Center
